Evaluation of 18F-2-deoxy-2-fluoro-D-glucose Positron Emission Tomography for Gastric Cancer

World Journal of Surgery

Volumn 28, Issue 3, 2004, Pages 247-253

  Mochiki, Erito ^a   Kuwano, Hiroyuki ^a   Katoh, Hiroyuki ^a   Asao, Takayuki ^a   Oriuchi, Noboru ^a   Endo, Keigo ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DRUG UPTAKE; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE QUALITY; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PERFORMANCE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PROGNOSIS; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; STOMACH CANCER;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; FEMALE; FLUORODEOXYGLUCOSE F18; GASTRECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; NEOPLASM STAGING; POSTOPERATIVE PERIOD; PROBABILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 1642345520     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-003-7191-5     Document Type: Article

References (40)

1. Inokuchi K. Prolonged survival of stomach cancer patients after extensive surgery and adjuvant treatment: an overview of the Japanese experiences. Semin. Surg. Oncol. 1991;7:333-338
2. Maehara Y, Kakeji Y, Oda S, et al. Time trends of surgical treatment and the prognosis for Japanese patients with gastric cancer. Br. J. Cancer 2000;83:986-991
3. Maruyama K, Sasako M, Kinoshita T, et al. Surgical treatment for gastric cancer: the Japanese approach. Semin. Oncol. 1996;23:360-368
4. Hiki Y, Shimao J, Yamao Y, et al. The concepts, procedures, and problems related in endoscopic laser therapy of early gastric cancer: a retrospective study on early gastric cancer. Surg. Endosc. 1989;3:1-6
5. Ohgami M, Otani Y, Kumai K, et al. Curative laparoscopic surgery for early gastric cancer: five years experience. World J. Surg. 1999;23:187-192
6. Marczell AP, Rosen HR, Hentschel E. Diagnosis and tactical approach to surgery for early gastric carcinoma: a retrospective analysis of the past 16 years in an Austrian general hospital. Gastroenterol. Jpn. 1989;24:732-736
7. Nakamura K, Morisaki T, Sugitani A, et al. An early gastric carcinoma treatment strategy based on analysis of lymph node metastasis. Cancer 1999;85:1500-1505
8. Fraser I, Nash R, James DC. Computed tomography in gastric cancer. Br. J. Surg. 1985;72:249-250
9. Andaker L, Morales O, Hojer H, et al. Evaluation of pre-operative computed tomography in gastric malignancy. Surgery 1991;109:132-135
10. Ziegler K, Sanft C, Zimmer T, et al. Comparison of computed tomography, endosonography, and intraoperative assessment in TN staging of gastric carcinoma. Gut 1993;34:604-610
11. Nattermann C, Dancygier H. Endosonography in diagnosis and staging of malignant tumors of the stomach: a prospective comparative study between endosonography, computerized tomography and conventional ultrasonography. Z. Gastroenterol. 1993;31:719-726
12. Wakelin SJ, Deans C, Crofts TJ, et al. A comparison of computerised tomography, laparoscopic ultrasound and endoscopic ultrasound in the preoperative staging of oesophago-gastric carcinoma. Eur. J. Radiol. 2002;41:161-167
13. Bar-Shalom R, Valdivia AY, Blaufox MD. PET imaging in oncology. Semin. Nucl. Med. 2000;30:150-185
14. Yasuda S, Raja S, Hubner KF. Application of whole-body positron emission tomography in the imaging of esophageal cancer. Surg. Today 1995;25:261-264
15. Valk PE, Pounds TR, Hopkins DM, et al. Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. Ann. Thorac. Surg. 1995;60:1573-1581
16. Viotola JV, Delbeke D, Sandler MP, et al. Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am. J. Surg. 1996;171:21-26
17. Kole AC, Plukker JT, Nieweg OE, et al. Positron emission tomography for staging oesophageal and gastroesophageal malignancy. Br. J. Cancer 1998;78:521-527
18. Mcateer D, Wallis F, Couper G, et al. Evaluation of 18F-FDG positron emission tomography in gastric and oesophageal carcinoma. Br. J. Radiol. 1999;72:525-529
19. Lerut T, Flamen P, Ectors N, et al. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: a prospective study based on primary surgery with extensive lymphadenectomy. Ann. Surg. 2000;232:743-752
20. Stahl A, Ott K, Weber WA, et al. FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings. Eur. J. Nucl. Med. 2003;30:288-295
21. De Potter T, Flamen P, Van Cutsem E, et al. Whole-body PET with FDG for the diagnosis of recurrent gastric cancer. Eur. J. Nucl. Med. Mol. Imaging 2002;29:525-529
22. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 2nd English edition. Gastric Cancer 1998;1:10-24
23. Inoue T, Oriuchi N, Kunio M, et al. Accuracy of standardized uptake value measured by simultaneous emission and transmission scanning in PET oncology. Nucl. Med. Commun. 1999;20:849-857
24. Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-(fluorine-18)-fluoro-deoxy-d-glucose: variations with body weight and a method for correction. Radiology 1993;189:847-850
25. Beck JR. Likelihood ratios: another enhancement of sensitivity and specificity. Arch. Pathol. Lab. Med. 1986;110:685-686
26. Flamen P, Lerut A, Van Cutsem E, et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J. Clin. Oncol. 2000;18:3202-3210
27. Flanagan FL, Dehdashti F, Siegel BA, et al. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. AJR. Am. J. Roentgenol. 1997;168:417-424
28. Block MI, Patterson GA, Sundaresan RS, et al. Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann. Thorac. Surg. 1997;64:770-776
29. Couper GW, McAteer D, Wallis F, et al. Detection of response to chemotherapy using positron emission tomography in patients with esophageal and gastric cancer. Br. J. Surg. 1998;85:1403-1406
30. Isselbacher KJ. Sugar and amino acid transport by cells in culture-differences between normal and malignant cells. N. Engl. J. Med. 1972;286:929-933
31. Yonekura Y, Benua RS, Brill AB, et al. Increased accumulation of 2-deoxy-2-[18F]fluoro-d-glucose in liver metastases from colon carcinoma. J. Nucl. Med. 1982;23:1133-1137
32. Flier JS, Mueckler MM, Usher P, et al. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 1987;235:1492-1495
33. Hiraki Y, Rosen OM, Birnbaum MJ. Growth factors rapidly induce expression of the glucose transporter gene. J. Biol. Chem. 1988;263:13655-13662
34. Merrall NW, Plevin R, Gould GW. Growth factors, mitogens, oncogenes, and the regulation of glucose transport. Cell. Signal. 1993;5:667-675
35. Mueckler M. Facilitative glucose transporters. Eur. J. Biochem. 1994;219:713-725
36. Yamamoto T, Seino Y, Fukumoto H, et al. Over-expression of facilitative glucose transporter genes in human cancer. Biochem. Biophys. Res. Commun. 1990;170:223-230
37. Younes M, Lechago LV, Lechago J. Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases. Clin. Cancer Res. 1996;2:1151-1154
38. Kawamura T, Kusakabe T, Sugino T, et al. Expression of glucose transporter-1 in human gastric carcinoma. Cancer 2001;92:634-641
39. Fukunaga T, Okazumi S, Koide Y, et al. Evaluation of esophageal cancers using fluorine-18-fluorodeoxyglucose PET. J. Nucl. Med. 1998;39:1002-1007
40. Higashi K, Ueda Y, Ayabe K, et al. FDG PET in the evaluation of the aggressiveness of pulmonary adenocarcinoma: correlation with histopathological features. Nucl. Med. Commun. 2000;21:707-714